Study Stopped
There was only one participant
Mechanical Intervention on the Scalp Microbiome: Setting the Stage for the Future Management of Cicatricial Alopecias
Effect of Mechanical Intervention on the Scalp Microbiome: Setting the Stage for the Future Management of Cicatricial Alopecias
1 other identifier
interventional
23
1 country
1
Brief Summary
The objective of this study is to assess the effect of standardized scalp care, specifically mechanical cleansing with the Venus Glow™ Device and water, on the scalp microbiome. This study also seeks to characterize the microbiome of the normal, healthy scalp, thereby providing a baseline for which the scalp affected by hair and scalp disease can be compared.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 13, 2023
CompletedFirst Submitted
Initial submission to the registry
February 27, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 13, 2024
CompletedFirst Posted
Study publicly available on registry
April 10, 2024
CompletedResults Posted
Study results publicly available
February 12, 2025
CompletedFebruary 12, 2025
January 1, 2025
6 months
February 27, 2023
October 24, 2024
January 21, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Scalp Microbiome Composition
as assessed by relative abundance of genera from scalp swab DNA extraction of the right and left mid-frontal scalp. Kruskal-Wallis will be used to assess variation in microbiome composition between treatment groups
Day 14
Secondary Outcomes (3)
Scalp Health
Assessed at day 1 (baseline).
Post-treatment 1 Right-sided Scalp Health
Assessed at day 7
Post-treatment 2 Right-sided Scalp Health
Assessed at day 14
Study Arms (1)
Healthy-experimental
EXPERIMENTALHealthy participants who have not been diagnosed with scalp or hair disease will be followed over a period of 2 weeks to assess their scalp microbiome and see how well the investigational device works on decreasing the microbe burden of the scalp.
Interventions
two treatments over a one week period. At the first visit they will complete an initial questionnaire regarding current scalp care practices, skin type, and hair type. An initial baseline scalp swab and HairMetrix photography in the two swab sites will be taken at the beginning of this visit. Treatment with the Venus Glow™ device will also occur. To treat, the scalp will be divided into four quadrants. Swab samples will be collected at the first baseline and concurrent treatment session, second treatment session and 3-6 days after the last treatment when participants have returned to their usual cleansing routine.
Eligibility Criteria
You may qualify if:
- All individuals between 18-35 years of age
- Ability to understand study procedures and to comply with them
You may not qualify if:
- Non-English speakers
- Current scalp or hair disease diagnosis
- Using oral or topical antimicrobial medication 4 weeks prior to their baseline visit or in the duration of the study
- Current clinical condition that, in the opinion of the site investigator, would interfere with adherence to study requirements
- Inability or unwillingness of individual to give written informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Minnesota
Minneapolis, Minnesota, 55455, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
The limitations of the trial are as follows: small sample size, short interim between treatment sessions, no scalp/hair disease group.
Results Point of Contact
- Title
- Ronda Farah
- Organization
- University of Minnesota
Study Officials
- PRINCIPAL INVESTIGATOR
Ronda Farah, MD
University of Minnesota
- PRINCIPAL INVESTIGATOR
Maria Hordinsky, MD
University of Minnesota
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 27, 2023
First Posted
April 10, 2024
Study Start
January 13, 2023
Primary Completion
June 30, 2023
Study Completion
January 13, 2024
Last Updated
February 12, 2025
Results First Posted
February 12, 2025
Record last verified: 2025-01